Publications
- Entrectinib v léčbě ROS1 pozitivního pokročilého nemalobuněčného plicního karcinomu a v léčbě solidních nádorů s NTRK fúzí2021 | First Faculty of Medicine
- Cancer Immunology2015 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Mitochondrially targeted tamoxifen in patients with metastatic solid tumours: an open-label, phase I/Ib single-centre trial2023 | First Faculty of Medicine, Faculty of Science, Central Library of Charles University, Faculty of Mathematics and Physics, Third Faculty of Medicine
- Mitochondrially targeted tamoxifen as anticancer therapy: case series of patients with renal cell carcinoma treated in a phase I/Ib clinical trial2023 | First Faculty of Medicine, Faculty of Science, Central Library of Charles University, Faculty of Mathematics and Physics, Third Faculty of Medicine
- Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer2023 | First Faculty of Medicine
- Komentář ke studii2023 | First Faculty of Medicine
- Přínos sekvenování nové generace v terapii nemalobuněčného plicního karcinomu - zaměřeno na rezistence u EGFR mutovaného nemalobuněčného plicního karcinomu2023 | First Faculty of Medicine
- Malignant pleural mesothelioma – case report2023 | First Faculty of Medicine
- Efficacy and toxicity of combined immunochemotherapy in the treatment of patients with bronchogenic carcinoma with PD-L1 receptor expression < 1 % - case report2023 | First Faculty of Medicine
- Fecal microbiota transplantation - new possibility to influence the results of therapy of cancer patients2022 | First Faculty of Medicine, Second Faculty of Medicine
Loading network view...